Search results

• 2021 results and resolutions

  View the resolutions and results from the AGM in 2021

• 2013 resolutions and results

  View the resolutions and results from the AGM in 2013

• 2025 Full Year Results

  Encouraging early progress delivering on our plan to grow earnings and improve returns.

• 2016 resolutions and results

  View the resolutions and results from the AGM in 2016

• 2025 Results and resolutions

  Croda has posted notice of its Annual General Meeting (“AGM”) to shareholders who elected to continue receiving documents from the Company in hard copy form.

• 2026 Resolutions and Results

  Croda has posted notice of its Annual General Meeting (“AGM”) to shareholders who elected to continue receiving documents from the Company in hard copy form.

• Croda supports Pfizer-BioNTech COVID-19 vaccine

  Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.

• Investing in organic expansion in Agriculture

  Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.

• Celebrating a century of Croda

  Croda marks 100 years with global celebrations highlighting our people, history, and commitment to our Purpose: Smart science to improve lives™.

• Making every minute count

  Take a look at how employees across the Croda Group have spent their 1% Club time helping their communities.

• International Day of Women and Girls in Science

  At Croda, we recognise that by championing gender equality in STEM, we can adopt a future where talent determines success; while promoting inclusivity, and empowering the next generation of female scientists, engineers, and innovators.

• International chemicals leader Croda expands presence at Techspace One

  Croda has expanded its presence at Sci-Tech Daresbury in line with plans to scale up its biotechnology capability.

• Croda urges G20 leaders to keep Paris Agreement within reach

  Croda is signatory to an open letter to all G20 leaders, urging them to keep the Paris Agreement’s 1.5°C goal within reach.

• Signatory to the if not now then when campaign

  We have joined over 70 major UK businesses in becoming a signatory to the Black inclusion business campaign.

• Directorate change and Full Year 2023 outlook confirmed

  18 December 2023: Croda International Plc today announces that Louisa Burdett, Chief Financial Officer, intends to leave the Company in June 2024.

• Delivering the foundation for Croda's R&D digital program

  Global Research and Development Digital Program across all R&D locations.

• Supporting Invisible Disabilities Week at Croda

  Learn how Croda supports Invisible Disabilities Week, promoting awareness and inclusivity for employees with hidden disabilities. Discover personal stories, like Sana Bell’s, and our commitment to creating a supportive workplace for everyone to thrive.

• Croda unveils Matrixyl® Neolide™, an iconic peptide with smarter delivery

  Croda introduces Matrixyl® Neolide™, an iconic peptide with smarter delivery, designed to maximise performance and unlock new possibilities in advanced skin care.

• Most Admired Company in the British Chemical Sector for the Fourth Year Running

  Voted Britain’s Most Admired Chemicals Company for the fourth year running, as well as being named Britain’s fifth Most Admired Company overall.

• Validation of our 1.5°C Science Based Targets

  We have become one of only three major chemical companies in the world to have our 1.5°C Science Based Targets validated.